Skip to Content

Kimberly-Clark Corp - Stock Quote KMB

Rating as of

Morningstar's Kimberly-Clark Corp Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Surging Sales Insufficient to Thwart Leaking Profits in Kimberly-Clark's Q1; Shares Not a Bargain

Erin Lash, CFA Sector Director

Analyst Note

| Erin Lash, CFA |

The market found favor with narrow-moat Kimberly-Clark’s swelling first-quarter sales growth metrics, sending shares up to the tune of nearly 10%. While we acknowledge a 10% jump in organic sales is impressive at first blush (composed of a 6% benefit from higher prices and 2% each from increased volumes and favorable mix), we don’t think it strikes the same chord when juxtaposed with the 8% decline posted in the year-ago period (which was constrained by weather-related disruptions and pantry destocking).

Read Full Analysis

Kimberly-Clark Corp's Company Profile

Business Description

With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

P.O. Box 619100
Dallas, TX, 75261-9100
T +1 972 281-1200
Sector Consumer Defensive
Industry Household & Personal Products
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2022
Stock Type Slow Growth
Employees 45,000

Kimberly-Clark Corp's Related Articles & News